Physician profile
Yinyin Jl Devoe
NPI 1427192434
$1,496.79
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $14.03 · 2021: $213 · 2024: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $565.98 | 2019 | |
| Biodelivery Sciences International, INC. | $149.76 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.48 | 2019-2024 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $142.10 | 2019 | |
| Grt US Holding, INC. | $121.05 | 2021 | |
| Edwards Lifesciences Corporation | $94.86 | 2024 | |
| Pfizer INC. | $87.57 | 2019 | |
| Allergan, INC. | $86.47 | 2019-2021 | |
| Daiichi Sankyo INC. | $49.60 | 2019 | |
| Pacira Therapeutics, INC. | $16.84 | 2019 | |
| Nevro Corp. | $12.67 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.82 | 2019 | |
| Horizon Therapeutics Plc | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yinyin Devoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.